CTRI/2019/06/019591
Not yet recruiting
Phase 3
Prospective Randomized double blinded study comparing Dexmedetomidine-Fentanyl with Dexmedetomidine-Nalbuphine for sedation and analgesia during upper gastrointestinal endoscopy procedure.
Ampolu kausalya0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ampolu kausalya
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patiens posted for upper gastrointestinal endoscopy
- •Elective procedures
- •ASA status one and two
Exclusion Criteria
- •Emergency procedure
- •Patient not willing
- •Allergic to drug
- •Patient on chronic opioid
- •ASA class three and four
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Comparison of the effectiveness of two nerve block pain management techniques in patients undergoing hip fracture repair surgeryHealth Condition 1: O- Medical and SurgicalCTRI/2024/05/066952Fortis Hospitals Limited
Completed
Phase 2
Comparing Adrenaline vs. combination of Adrenaline dexmedetomidine in Ear and Nose surgeriesHealth Condition 1: null- Patients with Tympanic membrane perforation for tympanoplasty and deviated nasal septum for septoplastyCTRI/2017/09/009627nil80
Not yet recruiting
Not Applicable
A study comparing effects of levo bupivacaine in two different concentration, in spinal anaesthesia.Health Condition 1: N00-N99- Diseases of the genitourinary systemCTRI/2022/03/040877Sir Gangaram Hospital
Not yet recruiting
Not Applicable
Study comparing short acting and long acting forms of drug used for increasing the uterine strength after surgical delivery of baby from mother.Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperiumCTRI/2022/10/046407Dr Gita Nath
Completed
Phase 2
Clinical study comparing the efficacy in the achievement of the remission (measured as reduction of proteinuria) and safety of two different doses of voclosporin and non active drug (placebo) in patients suffering from active lupus nephritisActive Lupus NephritisSLCTR/2015/001Aurinia Pharmaceuticals Inc.